InvestorsHub Logo

jondoeuk

04/25/21 4:16 PM

#372397 RE: longfellow95 #371497

Most, if not all these barriers can be overcome using cell based therapies. With vaccines they can't, even when you add mAbs and/or small molecules, which increase costs and toxicities. Worse still, it is rare that vaccines induce high enough levels of T-cells to impact the disease, and targets matter as well https://cancerres.aacrjournals.org/content/80/16_Supplement/6680 https://cancerres.aacrjournals.org/content/79/13_Supplement/943